---
title: "Beckman Coulter Diagnostics wins CE mark for Access p-Tau217 Alzheimer’s blood test in Europe"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291925507.md"
description: "Beckman Coulter Diagnostics, a Danaher unit, has received the CE Mark under IVDR for its Access p-Tau217 Alzheimer’s blood test in Europe. This test targets amyloid pathology assessment in patients with cognitive decline to broaden clinical adoption of blood-based biomarkers. Additionally, Beckman launched Access BD-pTau217, a higher-specificity assay for research use only. Both assays operate on the DxI 9000 immunoassay analyzer."
datetime: "2026-07-07T11:36:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291925507.md)
  - [en](https://longbridge.com/en/news/291925507.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291925507.md)
---

# Beckman Coulter Diagnostics wins CE mark for Access p-Tau217 Alzheimer’s blood test in Europe

-   Danaher unit Beckman Coulter Diagnostics received CE Mark under IVDR for its Access p-Tau217 Alzheimer’s blood test in Europe. \* Test targets amyloid pathology assessment in patients showing cognitive decline, aiming to broaden routine clinical adoption of blood-based biomarkers. \* Beckman also launched Access BD-pTau217, a higher-specificity brain-derived pTau217 assay for research use only. \* Both assays run on the DxI 9000 immunoassay analyzer, positioning a single platform for clinical testing alongside neurodegenerative research workflows. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607070300PR\_NEWS\_USPR\_\_\_\_\_LA98957) on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)

## Related News & Research

- [BUZZ-Street View: Bioprocess woes weigh on Danaher, but bulls stay put](https://longbridge.com/en/news/293441431.md)
- [Key facts: Danaher strong cash; trims 2026 outlook; bio orders, $100M deferred](https://longbridge.com/en/news/293434927.md)
- [Stock Of The Day: Is The Danaher Selloff Over?](https://longbridge.com/en/news/293517409.md)
- [Danaher unit Cepheid unveils third-generation GeneXpert system at ADLM 2026](https://longbridge.com/en/news/293477376.md)
- [Beckman Coulter Diagnostics launches DxU 1800 automated urinalysis system in US](https://longbridge.com/en/news/293617835.md)